S‐1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas

Overview of attention for article published in World Journal of Surgery, August 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 1 X post from an account with 825 followers.

S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas. http://t.co/LcuT5O1HoC

Reply Repost Favourite